BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24281860)

  • 21. Hepatopathy-thrombocytopenia syndrome (HTS) after actinomycin-D therapy: report of three cases and review of the literature.
    Farruggia P; Macaluso A; Tropia S; Di Marco F; Russo D; Grigoli A; Trizzino A; D'Angelo P
    Pediatr Hematol Oncol; 2011 Apr; 28(3):237-43. PubMed ID: 21271778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actinomycin D associated hepatic veno-occlusive disease--a report of 2 cases.
    Barclay KL; Yeong ML
    Pathology; 1994 Jul; 26(3):257-60. PubMed ID: 7991279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.
    Ho VT; Revta C; Richardson PG
    Bone Marrow Transplant; 2008 Feb; 41(3):229-37. PubMed ID: 17994121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wilms' tumor complicated by veno-occlusive disease of the liver (VOD): current concepts and a case report.
    Nybonde T
    Pediatr Hematol Oncol; 1989; 6(4):389-90. PubMed ID: 2561917
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment with high-dose methylprednisolone for hepatic veno-occlusive disease in a child with rhabdomyosarcoma.
    Chen IL; Yang SN; Hsiao CC; Wu KS; Sheen JM
    Pediatr Neonatol; 2008 Aug; 49(4):141-4. PubMed ID: 19054920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wilms' tumor complicated by veno-occlusive disease of the liver (VOD): current concepts and a case report.
    Nybonde T; Eklöf O; Björk O
    Pediatr Hematol Oncol; 1988; 5(1):53-60. PubMed ID: 2856364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group.
    Feusner JH; Ritchey ML; Norkool PA; Takashima JR; Breslow NE; Green DM
    Pediatr Blood Cancer; 2008 Feb; 50(2):242-5. PubMed ID: 17458877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
    Corbacioglu S; Kernan N; Lehmann L; Brochstein J; Revta C; Grupp S; Martin P; Richardson PG
    Expert Rev Hematol; 2012 Jun; 5(3):291-302. PubMed ID: 22780209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic Sinusoidal Obstruction Syndrome in a child after chemotherapy for medulloblastoma.
    Ishaqi MK; Jamil A; Khanani M; Baroudi M; Trad O; El-Hayek M; Bouffet E
    J Neurooncol; 2010 Mar; 97(1):137-41. PubMed ID: 19701718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Veno-occlusive disease in pediatric patients receiving actinomycin D and vincristine only for the treatment of rhabdomyosarcoma.
    Sulis ML; Bessmertny O; Granowetter L; Weiner M; Kelly KM
    J Pediatr Hematol Oncol; 2004 Dec; 26(12):843-6. PubMed ID: 15591910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Veno-occlusive disease of the liver in a child after chemotherapy for brain tumor.
    Elli M; Pinarli FG; Dagdemir A; Acar S
    Pediatr Blood Cancer; 2006 Apr; 46(4):521-3. PubMed ID: 16317738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sinusoidal obstruction syndrome during induction therapy for acute lymphoblastic leukemia managed with N-acetyl Cysteine.
    Sahoo RK; Sharma A
    Pediatr Blood Cancer; 2011 Oct; 57(4):700. PubMed ID: 21656901
    [No Abstract]   [Full Text] [Related]  

  • 33. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide.
    Shah MS; Jeevangi NK; Joshi A; Khattry N
    J Cancer Res Ther; 2009; 5(4):312-4. PubMed ID: 20160371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.
    Gao H; Li N; Wang JY; Zhang SC; Lin G
    J Dig Dis; 2012 Jan; 13(1):33-9. PubMed ID: 22188914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group.
    Kalapurakal JA; Nan B; Norkool P; Coppes M; Perlman E; Beckwith B; Ritchey M; Breslow N; Grundy P; D'angio GJ; Green DM; Thomas PR
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1379-84. PubMed ID: 15590168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment with danhong injection for hepatic veno-occlusive disease.
    Yao JY; Zhi M; Cao WT; Huang Y; Li CJ
    Hepatogastroenterology; 2011; 58(107-108):992-5. PubMed ID: 21830430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute malnutrition is common in Malawian patients with a Wilms tumour: A role for peanut butter.
    Israëls T; Borgstein E; Jamali M; de Kraker J; Caron HN; Molyneux EM
    Pediatr Blood Cancer; 2009 Dec; 53(7):1221-6. PubMed ID: 19821536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk stratification and consecutive prognosis progresses in childhood Wilms tumors. Two cases report.
    Diaconescu S; Olaru C; Mihailă D; Aprodu SG; Miron I
    Chirurgia (Bucur); 2013; 108(1):106-11. PubMed ID: 23464780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic Sinusoidal Obstruction Syndrome Induced by Non-transplant Chemotherapy for Non-Hodgkin Lymphoma.
    Sakumura M; Tajiri K; Miwa S; Nagata K; Kawai K; Miyazono T; Arita K; Wada A; Murakami J; Sugiyama T
    Intern Med; 2017; 56(4):395-400. PubMed ID: 28202860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.